ADMA Biologics, Inc.

US$12.73As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ADMAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 8.58%
Div yield —
ROE 41.95%
Biotechnology
Beta (5Y) 0.66
PE TTM 16.51
TSR TTM (17.76%)
Mkt cap US$2.824B
ROIC 36.54%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
15.40%
(64.95%)
Hold 2|7|3|7|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.13
0.13
0.14
0.15
10.23%
10.74%
16.63%
24.00%
Revenue$M
338.2
335.3
328.2
324.1
8.07%
2.92%
(2.96%)
(4.24%)
Peers (US$2.824B)
Cap (US$)
PE
2.787B
88.55x
2.683B
—
2.865B
—
Capital
TTM
5Y
10Y
Leveragex
0.506
(0.039)
(0.039)
EBIT/Intx
0.354
0.668
0.593
Own earn%
35.40
40.31
38.29
Sh yield%
50.21
48.51
44.72
Owners
Insiders/Inst%
13.10
73.74
Short interest%
2.29
SBC / revenue%
3.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
5–11
$1 testx
—
Incr. ROIC%
15